And I think for their next trick, after getting NIH to fund the original covid ARDS, is hopefully CIBMTR funding adult label extension for GvHD and NIH funding all cause ARDS.
Then add in a bombshell partnership for CHF post the FDA meeting, and a CLBP distributer, and they are set to speed things up again. 2023 is the year!
And I think for their next trick, after getting NIH to fund the...
-
- There are more pages in this discussion • 2,220 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.010(0.92%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.12 | $1.07 | $1.659M | 1.515M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 8899 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 106694 | 15 |
View Market Depth
| Last trade - 12.23pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |